4//SEC Filing
FIVE PRIME THERAPEUTICS INC 4
Accession 0001123292-14-000867
CIK 0001175505operating
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 5:15 PM ET
Size
5.3 KB
Accession
0001123292-14-000867
Insider Transaction Report
Form 4
Kavanaugh William Michael
SVP & Chief Scientific Officer
Transactions
- Award
Employee Stock Option (right to buy)
2014-08-22+15,000→ 15,000 totalExercise: $11.14Exp: 2024-08-21→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]One forty-eighth of the shares underlying the option will vest monthly beginning on September 22, 2014.
Documents
Issuer
FIVE PRIME THERAPEUTICS INC
CIK 0001175505
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001175505
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 5:15 PM ET
- Size
- 5.3 KB